93.31
price up icon2.11%   1.93
pre-market  Pre-mercato:  93.85   0.54   +0.58%
loading

Perché le azioni Alcon Inc (ALC) sono in ribasso?

Abbiamo notato un calo di 6.46% nelle azioni di Alcon Inc (ALC) durante la sessione di negoziazione di 2025-04-04. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-11-15:

Shares of Alcon Inc. (ALC) dropped by 5.91% from $74.96 to $70.53 in the trading on Wednesday, Novemeber 15, 2023. The reason why ALC is down today is due to disappointing Q3 sales and a revised full-year forecast.

  • Q3 sales: In Q3 2023, Alcon reported core EPS of 66 cents, up 32% YoY (41% at CER), missing estimates by 1.5%. Diluted EPS was 41 cents, a 78% increase from the previous year. Q3 net sales reached $2.30 billion, missing estimates by 1.6%, with an 8.4% YoY increase (9% at CER). In segment performance, sales in surgical came at $1.28 billion, up 5% YoY (6% at CER), but below estimates; meanwhile, sales in vision care hit $1.00 billion, up 13% YoY, exceeding projections.
  • Full year outlook: Alcon provided an updated outlook for the full year 2023, anticipating net sales in the range of $9.3 billion to $9.4 billion (previously $9.3 billion to $9.5 billion). This revised range suggests a growth rate of 10-11% at CER compared to 2022, up from the earlier projected growth of 9-11%. The Zacks Consensus Estimate for ALC’s revenues is pegged at $9.48 billion.
medical_instruments_supplies BDX
$199.88
price up icon 1.66%
medical_instruments_supplies RMD
$214.08
price up icon 1.52%
medical_instruments_supplies COO
$79.79
price up icon 1.39%
medical_instruments_supplies WST
$215.13
price up icon 4.49%
medical_instruments_supplies BAX
$28.62
price up icon 0.28%
Capitalizzazione:     |  Volume (24 ore):